Prospective Electronic Polygenic Risk Study

NCT05072275 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2022-11-07

No results posted yet for this study

Summary

This study will investigate the role of polygenic risk scores (PRS) in preventive health.

Conditions

Sponsors & Collaborators

  • Illumina, Inc.

    collaborator INDUSTRY
  • Quest Diagnostics-Nichols Insitute

    collaborator INDUSTRY
  • Scripps Translational Science Institute

    lead OTHER

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-31
Primary Completion
2023-11-30
Completion
2023-11-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05072275 on ClinicalTrials.gov